ABSTRACT
Food and water are rewarding in part because they satisfy our internal needs1,2. Dopaminergic neurons in the ventral tegmental area (VTA) are activated by gustatory rewards3-5, but how animals learn to associate these oral cues with the delayed physiological effects of ingestion is unknown. Here we show that individual dopaminergic neurons in the VTA respond to detection of nutrients or water at specific stages of ingestion. A major subset of dopaminergic neurons tracks changes in systemic hydration that occur tens of minutes after thirsty mice drink water, whereas different dopaminergic neurons respond to nutrients in the gastrointestinal tract. We show that information about fluid balance is transmitted to the VTA by a hypothalamic pathway and then re-routed to downstream circuits that track the oral, gastrointestinal and post-absorptive stages of ingestion. To investigate the function of these signals, we used a paradigm in which a fluid's oral and post-absorptive effects can be independently manipulated and temporally separated. We show that mice rapidly learn to prefer one fluid over another based solely on its rehydrating ability and that this post-ingestive learning is prevented if dopaminergic neurons in the VTA are selectively silenced after consumption. These findings reveal that the midbrain dopamine system contains subsystems that track different modalities and stages of ingestion, on timescales from seconds to tens of minutes, and that this information is used to drive learning about the consequences of ingestion.
Subject(s)
Dopamine , Dopaminergic Neurons , Hypothalamus , Neural Pathways , Nutrients , Organism Hydration Status , Ventral Tegmental Area , Animals , Cues , Digestion , Dopamine/metabolism , Dopaminergic Neurons/physiology , Eating , Gastrointestinal Tract/metabolism , Hypothalamus/cytology , Hypothalamus/physiology , Mesencephalon/cytology , Mesencephalon/physiology , Mice , Nutrients/metabolism , Organism Hydration Status/drug effects , Reward , Time Factors , Ventral Tegmental Area/cytology , Ventral Tegmental Area/physiology , Water/metabolism , Water/pharmacology , Water-Electrolyte BalanceABSTRACT
The prefrontal cortex is involved in goal-directed behavior. Here, we investigate circuits of the PFC regulating motivation, reinforcement, and its relationship to dopamine neuron activity. Stimulation of medial PFC (mPFC) neurons in mice activated many downstream regions, as shown by fMRI. Axonal terminal stimulation of mPFC neurons in downstream regions, including the anteromedial thalamic nucleus (AM), reinforced behavior and activated midbrain dopaminergic neurons. The stimulation of AM neurons projecting to the mPFC also reinforced behavior and activated dopamine neurons, and mPFC and AM showed a positive-feedback loop organization. We also found using fMRI in human participants watching reinforcing video clips that there is reciprocal excitatory functional connectivity, as well as co-activation of the two regions. Our results suggest that this cortico-thalamic loop regulates motivation, reinforcement, and dopaminergic neuron activity.
Subject(s)
Dopaminergic Neurons , Goals , Animals , Axons , Dopaminergic Neurons/physiology , Humans , Mice , Neural Pathways/physiology , Prefrontal Cortex/physiology , ThalamusABSTRACT
Parkinson's disease (PD) is a chronic and progressive neurodegenerative disease caused by degeneration of dopaminergic neurons in the substantia nigra. Existing pharmaceutical treatments offer alleviation of symptoms but cannot delay disease progression and are often associated with significant side effects. Clinical studies have demonstrated that acupuncture may be beneficial for PD treatment, particularly in terms of ameliorating PD symptoms when combined with anti-PD medication, reducing the required dose of medication and associated side effects. During early stages of PD, acupuncture may even be used to replace medication. It has also been found that acupuncture can protect dopaminergic neurons from degeneration via antioxidative stress, anti-inflammatory, and antiapoptotic pathways as well as modulating the neurotransmitter balance in the basal ganglia circuit. Here, we review current studies and reflect on the potential of acupuncture as a novel and effective treatment strategy for PD. We found that particularly during the early stages, acupuncture may reduce neurodegeneration of dopaminergic neurons and regulate the balance of the dopaminergic circuit, thus delaying the progression of the disease. The benefits of acupuncture will need to be further verified through basic and clinical studies.
Subject(s)
Acupuncture Therapy , Dopaminergic Neurons/physiology , Parkinson Disease/therapy , Antiparkinson Agents/therapeutic use , Apoptosis , Basal Ganglia/physiopathology , Bibliometrics , Clinical Trials as Topic , Combined Modality Therapy , Dopamine/metabolism , Humans , Nerve Net/physiopathology , Neuroinflammatory Diseases , Oxidative Stress , Parkinson Disease/drug therapy , Parkinson Disease/physiopathology , Protein Aggregation, Pathological , Treatment Outcome , alpha-Synuclein/analysisABSTRACT
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by a disorder of both the motor and nonmotor systems due to a loss of dopaminergic (DA) neurons. Herein, we aimed to investigate the potential neuroprotective role of Schisandra chinensis (Sch) and to determine the mechanism by which Sch functions to ameliorate PD in a 6-hydroxydopamin (6-OHDA)-induced PD model. The open field test, sucrose preference test, and Y-maze test were utilized to evaluate the motor and nonmotor symptoms. We found that administration of Sch improved both disorders and DA neurodegeneration in 6-OHDA-induced mice. Additional data confirmed that Sch treatment significantly increased BDNF expression and decreased the activity of GSK-3ß in the striatum and hippocampus. Moreover, Sch was able to alleviate the abnormal levels of ROS and increase SOD by boosting Nrf2 expression. The nuclear translocation of NF-κB was inhibited by Sch, which subsequently led to a downregulation of proinflammatory cytokines. Sch effectively suppressed apoptosis by decreasing expressions of caspase 3, caspase 9, and p53 in the PD mouse model. Our findings demonstrate that Sch protects against DA neurodegeneration in 6-OHDA-induced PD mice by suppressing oxidative stress, neuroinflammation and apoptosis through the involvement of the BDNF/Nrf2/NF-κB signaling pathway.
Subject(s)
Dopaminergic Neurons/physiology , Drugs, Chinese Herbal/therapeutic use , Neuroprotective Agents/therapeutic use , Parkinsonian Disorders/drug therapy , Parkinsonian Disorders/physiopathology , Schisandra , Animals , Apoptosis , Brain-Derived Neurotrophic Factor/metabolism , Corpus Striatum/metabolism , Cytokines/metabolism , Disease Models, Animal , Dopamine/metabolism , Hippocampus/metabolism , Mice , Mice, Inbred C57BL , NF-E2-Related Factor 2/metabolism , NF-kappa B/metabolism , Oxidative Stress , Oxidopamine , Parkinsonian Disorders/chemically induced , Phytotherapy , Signal TransductionABSTRACT
The objective of the study was to identify brain structures that mediate reward as evidenced by positive reinforcing effects of stimuli on behavior. Testing by intracerebral self-stimulation enabled monkeys to inform whether activation of ~2900 sites in 74 structures of 4 sensorimotor pathways and 4 modulatory loop pathways was positive, negative or neutral. Stimulation was rewarding at 30% of sites, negative at 17%, neutral at 52%. Virtually all (99%) structures yielded some positive or negative sites, suggesting a ubiquitous distribution of pathways transmitting valence information. Mapping of sites to structures with dense versus sparse dopaminergic (DA) or noradrenergic (NA) innervation showed that stimulation of DA-pathways was rewarding or neutral. Stimulation of NA-pathways was not rewarding. Stimulation of association areas was generally rewarding; stimulation of purely sensory or motor structures was generally negative. Reward related more to structures' sensorimotor function than to density of DA-innervation. Stimulation of basal ganglia loop pathways was rewarding except in lateral globus pallidus, an inhibitory structure in the negative feedback loop; stimulation of the cerebellar loop was rewarding in anterior vermis and the spinocerebellar pathway; and stimulation of the hippocampal CA1 loop was rewarding. While most positive sites were in the DA reward system, numerous sites in sparsely DA-innervated posterior cingulate and parietal cortices may represent a separate reward system. DA-density represents concentrations of plastic synapses that mediate acquisition of new synaptic connections. DA-sparse areas may represent innate, genetically programmed reward-associated pathways. Implications of findings in regard to response habituation and addiction are discussed.
Subject(s)
Brain/physiology , Reward , Self Stimulation/physiology , Animals , Basal Ganglia/physiology , Biofeedback, Psychology , Brain Mapping , Dopamine/physiology , Dopaminergic Neurons/physiology , Macaca mulatta , Male , Neural Pathways/physiology , Neuronal Plasticity/physiology , Norepinephrine/metabolism , Sympathetic Nervous System/physiologyABSTRACT
Treatment of depression is hampered by the failure to identify distinct symptom profiles with distinct pathophysiologies that differentially respond to distinct treatments. We posit that inflammatory depression is a meaningful depression subtype associated with specific symptoms and biological abnormalities. We review several upstream, potentially causative, mechanisms driving low-grade inflammation in this subtype of depression. We also discuss downstream mechanisms mediating the link between inflammation and symptoms of depression, including alterations in dopaminergic neurotransmission and tryptophan metabolism. Finally, we review evidence for several non-pharmacological interventions for inflammatory depression, including probiotics, omega-3 fatty acids, and physical exercise interventions. While some evidence suggests that these interventions may be efficacious in inflammatory depression, future clinical trials should consider enriching patient populations for inflammatory markers, or stratify patients by inflammatory status, to confirm or refute this hypothesis.
Subject(s)
Depression/pathology , Depressive Disorder, Major/pathology , Exercise Therapy/methods , Fatty Acids, Omega-3/therapeutic use , Gastrointestinal Microbiome/physiology , Probiotics/therapeutic use , C-Reactive Protein/analysis , C-Reactive Protein/cerebrospinal fluid , Depression/immunology , Depression/therapy , Depressive Disorder, Major/therapy , Dopaminergic Neurons/physiology , Dysbiosis/microbiology , Exercise/physiology , Humans , Inflammation/pathology , Inflammation/psychology , Synaptic Transmission/physiology , Tryptophan/metabolismABSTRACT
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of midbrain dopaminergic (DA) neurons. Neural stem cells (NSCs) are the most promising cells for cell-replacement therapy for PD. However, the poor differentiation and maturation of DA neurons and decreased cell survival after transplantation are a challenge. Tetrahydroxystilbene glucoside (2,3,5,4'-tetrahydroxystilbene-2-O-glucoside; TSG), an active component of the popular traditional Chinese medicinal plant Polygonum multiï¬orum Thunb, possesses multiple pharmacological actions. In this study, we determined whether TSG can induce neural stem cell (NSCs) differentiation into neurons, especially DA neurons, and the possible involvement of Wnt/ß-catenin signaling pathways. Results revealed that NSCs differentiated primarily into astrocytes when cultured in 2 % serum-containing medium. However, TSG treatment during NSC differentiation in vitro increased the number of Tuj-1-positive neurons, as well as the proportion of tyrosine hydroxylase(TH)-positive cells and dopamine- transporter- positive neurons, a late marker of mature DA neurons. We also found that TSG enhanced the expression of nuclear receptor related factor 1, a transcription factor specific for the development and maintenance of midbrain DA neurons in inducing NSC differentiation into TH -immunoreactive DA neurons. Moreover, TSG upregulated the expression of Wnt/ß-catenin signaling molecules (Wnt1, Wnt3a, Wnt5a, and ß-catenin). However, these promoting effects were significantly inhibited by the application of IWR1, a Wnt signaling-specific blocker in culture. Our findings suggested that TSG may have potential in inducing the DA neuronal differentiation of mouse NSCs mediated by triggering the Wnt/ß-catenin signaling pathway. These results indicated the possible role for TSG in the transplantation of NSCs for PD.
Subject(s)
Cell Differentiation/drug effects , Dopaminergic Neurons/drug effects , Glucosides/pharmacology , Mesencephalon/drug effects , Neural Stem Cells/drug effects , Stilbenes/pharmacology , Animals , Cell Differentiation/physiology , Cells, Cultured , Dopaminergic Neurons/physiology , Female , Glucosides/therapeutic use , Mesencephalon/cytology , Mesencephalon/physiology , Mice , Mice, Inbred BALB C , Neural Stem Cells/physiology , Parkinson Disease/physiopathology , Parkinson Disease/therapy , Pregnancy , Stilbenes/therapeutic use , Wnt Signaling Pathway/drug effects , Wnt Signaling Pathway/physiologyABSTRACT
OBJECTIVE: Parkinson's Disease (PD) is a neurodegenerative disease caused by the loss of dopaminergic neurons. Cognitive impairments have been reported using the event-related potential (ERP) technique. Patients show reduced novelty P3 (nP3) amplitudes in oddball experiments, a response to infrequent, surprising stimuli, linked to the orienting response of the brain. The nP3 is thought to depend on dopaminergic neuronal pathways though the effect of dopaminergic medication in PD has not yet been investigated. METHODS: Twenty-two patients with PD were examined "on" and "off" their regular dopaminergic medication in a novelty 3-stimulus-oddball task. Thirty-four healthy controls were also examined over two sessions, but received no medication. P3 amplitudes were compared throughout experimental conditions. RESULTS: All participants showed sizeable novelty difference ERP effects, i.e. ndP3 amplitudes, during both testing sessions. An interaction of diagnosis, medication and testing order was also found, indicating that dopaminergic medication modulated ndP3 in patients with PD across the two testing sessions: We observed enhanced ndP3 amplitudes from PD patients who were off medication on the second testing session. CONCLUSION: Patients with PD 'off' medication showed ERP evidence for repetition-related enhancement of novelty responses. Dopamine depletion in neuronal pathways that are affected by mid-stage PD possibly accounts for this modulation of novelty processing. SIGNIFICANCE: The data in this study potentially suggest that repetition effects on novelty processing in patients with PD are enhanced by dopaminergic depletion.
Subject(s)
Dopaminergic Neurons/physiology , Event-Related Potentials, P300/physiology , Parkinson Disease/physiopathology , Psychomotor Performance/physiology , Reaction Time/physiology , Acoustic Stimulation/methods , Aged , Dopamine Agents/pharmacology , Dopamine Agents/therapeutic use , Dopaminergic Neurons/drug effects , Electroencephalography/methods , Event-Related Potentials, P300/drug effects , Female , Humans , Male , Middle Aged , Parkinson Disease/drug therapy , Psychomotor Performance/drug effects , Reaction Time/drug effectsABSTRACT
Interindividual variation in behavior and brain activity is universal and provides substrates for natural selection [1-9]. Selective pressures shift the expression of behavioral traits at the population level [10, 11], but the accompanying changes of the underlying neural circuitry have rarely been identified [12, 13]. Selection likely acts through the genetic and/or epigenetic underpinnings of neural activity controlling the selected behavior [14]. Endocrine and neuromodulatory systems participate in behavioral diversity and could provide the substrate for evolutionary modifications [15-21]. Here, we examined brain-wide patterns of activity in larval zebrafish selectively bred over two generations for extreme differences in habituation of the acoustic startle response (ASR) [22]. The ASR is an evolutionarily conserved defensive behavior induced by strong acoustic/vibrational stimuli. ASR habituation shows great individual variability that is stable over days and heritable [4, 22]. Selection for high ASR habituation leads to stronger sound-evoked activation of ASR-processing brain areas. In contrast, animals selected for low habituation displayed stronger spontaneous activity in ASR-processing centers. Ablation of dopaminergic tyrosine hydroxylase (TH) neurons decreased ASR sensitivity. Independently selected ASR habituation lineages link the effect of behavioral selection to dopaminergic caudal hypothalamus (HC) neurons [23]. High ASR habituation co-segregated with decreased spontaneous swimming phenotypes, but visual startle responses were unaffected. Furthermore, high- and low-habituation larvae differed in stress responses as adults. Thus, selective pressure over a couple of generations on ASR habituation behavior is able to induce substantial differences in brain activity, carrying along additional behaviors as piggyback traits that might further affect fitness in the wild. VIDEO ABSTRACT.
Subject(s)
Acoustic Stimulation , Brain/physiology , Habituation, Psychophysiologic , Larva/physiology , Nervous System Physiological Phenomena , Reflex, Startle , Zebrafish/physiology , Animals , Dopaminergic Neurons/cytology , Dopaminergic Neurons/physiology , Hypothalamus/cytology , Hypothalamus/physiologySubject(s)
Central Nervous System Agents/therapeutic use , Depression/drug therapy , Molecular Targeted Therapy/trends , Organic Cation Transport Proteins/antagonists & inhibitors , Therapies, Investigational/trends , Affect/drug effects , Affect/physiology , Animals , Central Nervous System Agents/isolation & purification , Central Nervous System Agents/pharmacology , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/physiology , Drug Development/methods , Drug Development/trends , Drug Evaluation, Preclinical , Humans , Molecular Targeted Therapy/methods , Organic Cation Transport Proteins/physiology , Therapies, Investigational/methodsABSTRACT
The hypothalamic tuberoinfundibular dopaminergic (TIDA) neurones are critical with respect to regulating prolactin secretion from the anterior pituitary. Under most physiological conditions, they are stimulated by prolactin to release dopamine into the median eminence which subsequently suppresses further prolactin secretion from the lactotrophs. During lactation, the TIDA neurones are known to undergo both electrophysiological and neurochemical changes that alleviate this negative-feedback, thus allowing circulating prolactin levels to rise. The present study aimed to determine whether TIDA neurone morphology, most notably spine density, is also modified during lactation. This was achieved by stereotaxically injecting the arcuate nucleus of female, tyrosine hydroxylase-promoter driven Cre-recombinase transgenic rats with Cre-dependent adeno-associated virus-expressing Brainbow. This resulted in the highly specifici transfection of between 10% and 30% of the TIDA neurones, thus allowing the morphologies on multiple individual neurones to be examined in a single hypothalamic slice. The transfected neurones exhibited a range of complex forms, including a diversity of soma and location of axonal origin. Neuronal spine counting showed that the density of somatic, but not dendritic, spines was significantly higher during lactation than at any other reproductive stage. There was also a significant fall in somatic spine density across the oestrous cycle from dioestrus to oestrus. Although the functional characteristics of the additional somatic spines have not been determined, if, as might be expected, they represent an increased excitatory input to the TIDA neurones, this could have important physiological implications by perhaps supporting altered neurotransmitter release at their neuroendocrine terminals. Enhanced excitatory input may, for example, favour the release of the opioid peptide enkephalin rather than dopamine, which is potentially significant because the expression of the peptide is known to increase in the TIDA neurones during lactation and, in contrast to dopamine, it stimulates rather than inhibits prolactin secretion from the pituitary.
Subject(s)
Dopaminergic Neurons/physiology , Estrous Cycle/physiology , Hypothalamus/physiology , Lactation/physiology , Neuronal Plasticity/physiology , Animals , Arcuate Nucleus of Hypothalamus , Axons/physiology , Dendritic Spines/physiology , Female , Hypothalamus/cytology , Neurons/physiology , Neurotransmitter Agents/metabolism , Presynaptic Terminals/metabolism , Rats , Rats, Long-Evans , Rats, Transgenic , Tyrosine 3-Monooxygenase/geneticsABSTRACT
The amygdala is a brain area critical for the formation of fear memories. However, the nature of the teaching signal(s) that drive plasticity in the amygdala are still under debate. Here, we use optogenetic methods to investigate the contribution of ventral tegmental area (VTA) dopamine neurons to auditory-cued fear learning in male mice. Using anterograde and retrograde labeling, we found that a sparse and relatively evenly distributed population of VTA neurons projects to the basal amygdala (BA). In vivo optrode recordings in behaving mice showed that many VTA neurons, among them putative dopamine neurons, are excited by footshocks, and acquire a response to auditory stimuli during fear learning. Combined cfos imaging and retrograde labeling in dopamine transporter (DAT) Cre mice revealed that a large majority of BA projectors (>95%) are dopamine neurons, and that BA projectors become activated by the tone-footshock pairing of fear learning protocols. Finally, silencing VTA dopamine neurons, or their axon terminals in the BA during the footshock, reduced the strength of fear memory as tested 1 d later, whereas silencing the VTA-central amygdala (CeA) projection had no effect. Thus, VTA dopamine neurons projecting to the BA contribute to fear memory formation, by coding for the saliency of the footshock event and by signaling such events to the basal amygdala.SIGNIFICANCE STATEMENT Powerful mechanisms of fear learning have evolved in animals and humans to enable survival. During fear conditioning, a sensory cue, such as a tone (the conditioned stimulus), comes to predict an innately aversive stimulus, such as a mild footshock (the unconditioned stimulus). A brain representation of the unconditioned stimulus must act as a teaching signal to instruct plasticity of the conditioned stimulus representation in fear-related brain areas. Here we show that dopamine neurons in the VTA that project to the basal amygdala contribute to such a teaching signal for plasticity, thereby facilitating the formation of fear memories. Knowledge about the role of dopamine in aversively motivated plasticity might allow further insights into maladaptive plasticities that underlie anxiety and post-traumatic stress disorders in humans.
Subject(s)
Amygdala/physiology , Dopaminergic Neurons/physiology , Evoked Potentials, Somatosensory/physiology , Fear/physiology , Fear/psychology , Learning/physiology , Ventral Tegmental Area/physiology , Acoustic Stimulation , Animals , Cues , Dopamine Plasma Membrane Transport Proteins , Electrophysiological Phenomena/physiology , Electroshock , Male , Mice , NeuroimagingABSTRACT
Many brain areas modulate their activity during vibrotactile tasks. The activity from these areas may code the stimulus parameters, stimulus perception, or perceptual reports. Here, we discuss findings obtained in behaving monkeys aimed to understand these processes. In brief, neurons from the somatosensory thalamus and primary somatosensory cortex (S1) only code the stimulus parameters during the stimulation periods. In contrast, areas downstream of S1 code the stimulus parameters during not only the task components but also perception. Surprisingly, the midbrain dopamine system is an actor not considered before in perception. We discuss the evidence that it codes the subjective magnitude of a sensory percept. The findings reviewed here may help us to understand where and how sensation transforms into perception in the brain.
Subject(s)
Dopaminergic Neurons/physiology , Mesencephalon/physiology , Somatosensory Cortex/physiology , Thalamus/physiology , Touch Perception/physiology , Touch/physiology , AnimalsABSTRACT
Parkinson's disease (PD) is characterized by dopaminergic neuron loss in the substantia nigra. However, specific sensory stimulation via electroacupuncture (EA) therapy may attenuate this loss by promoting the expression of endogenous neurotrophic factors in a manner similar to physical therapy. We investigated the potential protective effects of EA on dopaminergic neurons in a mouse model of PD and whether these effects are associated with the promotion of endogenous brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF). Mouse models of PD were generated using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6-hydroxydopamine. Motor performance was assessed using behavioral tests, and Western blot experiments, enzyme-linked immunosorbent assays (ELISAs), and immunohistochemical assays were performed. In both mouse models, EA treatment ameliorated motor impairments and dopaminergic neuron loss; these changes were accompanied by increases in BDNF and GDNF. In the MPTP group, EA treatment improved motor dysfunction by attenuating dopaminergic neuron loss in the substantia nigra, similar to the effects of levodopa. EA treatment significantly upregulated BDNF and GDNF expression in both the substantia nigra and striatum. Moreover, EA treatment induced the expression of cAMP response element binding protein (CREB) as well as Akt and Pitx3 in dopaminergic neurons in the substantia nigra. However, levodopa treatment did not induce BDNF/GDNF activation or related signaling factors. Thus, EA therapy may exert protective effects on dopaminergic neurons by upregulating the expression of BDNF, GDNF, and related signaling factors, thereby improving motor function. Hence, EA may represent an effective adjuvant therapy for motor deficits in patients with PD.
Subject(s)
Brain-Derived Neurotrophic Factor/physiology , Electroacupuncture , Glial Cell Line-Derived Neurotrophic Factor/physiology , Parkinson Disease/physiopathology , Parkinson Disease/therapy , Animals , Corpus Striatum/pathology , Corpus Striatum/physiopathology , Disease Models, Animal , Dopaminergic Neurons/pathology , Dopaminergic Neurons/physiology , Humans , Male , Mice , Mice, Inbred C57BL , Nerve Degeneration/pathology , Nerve Degeneration/therapy , Oxidopamine/toxicity , Parkinson Disease/pathology , Parkinsonian Disorders/pathology , Parkinsonian Disorders/physiopathology , Parkinsonian Disorders/therapy , Signal Transduction , Substantia Nigra/pathology , Substantia Nigra/physiopathologyABSTRACT
The brain renin-angiotensin system plays a vital role in the modulation of the neuroinflammatory responses and the progression of dopaminergic (DA) degeneration. Angiotensin II (Ang II) induces microglia activation via angiotensin II type 1 receptor (AT1R), which in turn affects the function of DA neurons. Endophilin A2 (EPA2) is involved in fast endophilin-mediated endocytosis and quickly endocytoses several G-protein-coupled receptor (GPCR), while AT1R belongs to GPCR family. Therefore, we speculated that EPA2 may modulate microglia activation via endocytosing AT1R. Biochanin A is an O-methylated isoflavone, classified as a kind of phytoestrogen due to its chemical structure that is similar to mammalian estrogens. In this study, we investigated the protective effects of biochanin A on Ang II-induced DA neurons damage in vivo, and molecular mechanisms. The results showed that biochanin A treatment for 7 days attenuated the behavioral dysfunction, inhibited the microglial activation, and prevented DA neuron damage in Ang II-induced rats. Furthermore, biochanin A increased EPA2 expression and decreased the expression of AT1R, gp91phox, p22 phox, NLRP3, ASC, Caspase-1, IL-1ß, IL-6, IL-18, and TNF-α. In summary, these results suggest that biochanin A exerts protective effects in Ang II-induced model rats, and the mechanisms may involve inhibition of inflammatory responses, an increase in EPA2 expression and a decrease in AT1R expression.
Subject(s)
Acyltransferases/metabolism , Dopaminergic Neurons/drug effects , Genistein/pharmacology , Acyltransferases/genetics , Angiotensin II/pharmacology , Animals , Dopaminergic Neurons/physiology , Genistein/metabolism , Inflammation , Lipopolysaccharides , Male , Microglia/metabolism , Neuroimmunomodulation/drug effects , Neuroimmunomodulation/physiology , Nitric Oxide/metabolism , Phytoestrogens/pharmacology , Protective Agents/pharmacology , Rats , Rats, Sprague-Dawley , Receptor, Angiotensin, Type 1/metabolism , Receptors, G-Protein-CoupledABSTRACT
There is behavioral evidence for the interaction between crude khat extract and the endocannabinoid system, whereby the endocannabinoid system alters khat extract-mediated behavioral effects through modulation of the monoaminergic system. The objective of this study was to investigate the role of the endocannabinoid system on the neurobehavioral effect of khat extract in mice following concomitant administration of khat extract and the CB2R agonist, JWH133. Locomotor activity test, immunohistochemistry, and reverse transcriptase polymerase chain reaction technique were utilized to assess locomotor activity, tyrosine hydroxylase immunoreactivity, and expression of dopamine transporter mRNA gene. The results show sub-acute administration of khat extract alone increased locomotor activity in mice and co-administration of the CB2R agonist, JWH133, reduced khat extract induced hyperlocomotor activity. The data revealed that cell type specific deletion of CB2Rs on dopaminergic neurons increased the hyperlocomotor behavior of khat extract. Furthermore, the results revealed that khat extract attenuated MPTP induced motor deficits, which is enhanced by JWH133. Khat extract also increased expression of tyrosine hydroxylase positive cells and expression of dopamine transporter mRNA gene in wild type mice. Nevertheless, JWH133 did not alter the effect of khat extract on tyrosine hydroxylase immunoreactivity and dopamine transporter mRNA expression when given together with khat extract. Taken together, the results suggest that the CB2Rs selectively interact with khat extract-mediated locomotor effects and could be utilized as therapeutic target in central nervous system movement disorders associated with dopamine dysregulation.
Subject(s)
Behavior, Animal/drug effects , Brain/physiology , Catha/chemistry , Plant Extracts/pharmacology , Receptor, Cannabinoid, CB2/metabolism , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , Animals , Brain/drug effects , Cannabinoids/administration & dosage , Cannabinoids/pharmacology , Dopamine Plasma Membrane Transport Proteins/genetics , Dopamine Plasma Membrane Transport Proteins/metabolism , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/physiology , Gene Deletion , Gene Expression Regulation/drug effects , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, Cannabinoid, CB2/agonists , Tyrosine 3-Monooxygenase/metabolismABSTRACT
AIMS: Maternal smoking is considered a risk factor for childhood obesity. In a rat model of tobacco exposure during breastfeeding, we previously reported hyperphagia, overweight, increased visceral fat and hyperleptinemia in adult female offspring. Obesity and eating disorders are associated with impairment in the endocannabinoid (EC) and dopaminergic (DA) systems. Considering that women are prone to eating disorders, we hypothesize that adult female Wistar rats that were exposed to cigarette smoke (CS) during the suckling period would develop EC and DA systems deregulation, possibly explaining the eating disorder in this model. MATERIAL AND METHODS: To mimic maternal smoking, from postnatal day 3 to 21, dams and offspring were exposed to a smoking machine, 4×/day/1â¯h (CS group). Control animals were exposed to ambient air. Offspring were evaluated at 26â¯weeks of age. KEY FINDINGS: Concerning the EC system, the CS group had increased expression of diacylglycerol lipase (DAGL) in the lateral hypothalamus (LH) and decreased in the liver. In the visceral adipose tissue, the EC receptor (CB1r) was decreased. Regarding the DA system, the CS group showed higher dopamine transporter (DAT) protein expression in the prefrontal cortex (PFC) and lower DA receptor (D2r) in the arcuate nucleus (ARC). We also assessed the hypothalamic leptin signaling, which was shown to be unchanged. CS offspring showed decreased plasma 17ß-estradiol. SIGNIFICANCE: Neonatal CS exposure induces changes in some biomarkers of the EC and DA systems, which can partially explain the hyperphagia observed in female rats.
Subject(s)
Dopaminergic Neurons/drug effects , Endocannabinoids/metabolism , Tobacco Smoke Pollution/adverse effects , Animals , Animals, Newborn , Cigarette Smoking , Dopamine/metabolism , Dopamine Plasma Membrane Transport Proteins/drug effects , Dopaminergic Neurons/physiology , Endocannabinoids/physiology , Female , Hypothalamic Area, Lateral/drug effects , Hypothalamic Area, Lateral/metabolism , Hypothalamus/metabolism , Lactation/drug effects , Leptin/metabolism , Lipoprotein Lipase/drug effects , Maternal Exposure/adverse effects , Obesity/etiology , Obesity/metabolism , Rats , Rats, Wistar , Receptors, Cannabinoid/drug effects , Smoking , NicotianaABSTRACT
Cortico-basal-ganglia-thalamic (CBGT) networks are critical for adaptive decision-making, yet how changes to circuit-level properties impact cognitive algorithms remains unclear. Here we explore how dopaminergic plasticity at corticostriatal synapses alters competition between striatal pathways, impacting the evidence accumulation process during decision-making. Spike-timing dependent plasticity simulations showed that dopaminergic feedback based on rewards modified the ratio of direct and indirect corticostriatal weights within opposing action channels. Using the learned weight ratios in a full spiking CBGT network model, we simulated neural dynamics and decision outcomes in a reward-driven decision task and fit them with a drift diffusion model. Fits revealed that the rate of evidence accumulation varied with inter-channel differences in direct pathway activity while boundary height varied with overall indirect pathway activity. This multi-level modeling approach demonstrates how complementary learning and decision computations can emerge from corticostriatal plasticity.
Subject(s)
Decision Making/physiology , Dopaminergic Neurons/physiology , Nerve Net/physiology , Animals , Basal Ganglia , Corpus Striatum , Feedback , Humans , Learning , Models, Neurological , Neural Pathways/physiology , Neuronal Plasticity/physiology , Neurons/physiology , Reinforcement, Psychology , Reward , Synapses/physiology , ThalamusABSTRACT
Neurokinin B, encoded by the tachykinin3 gene, plays a crucial role in regulating reproduction in mammals via KNDy neurons and interaction with GnRH. Previous work in teleost fishes has focused on hypothalamic tac3 expression for its role in reproduction, but detailed studies on extra-hypothalamic tac3 expression are limited. Here, we identified two tac3 genes in the social African cichlid fish Astatotilapia burtoni, only one of which produces a functional protein containing the signature tachykinin motif. In situ hybridization for tac3a mRNA identified cell populations throughout the brain. Numerous tac3a cells lie in several thalamic and hypothalamic nuclei, including periventricular nucleus of posterior tuberculum, lateral tuberal nucleus (NLT), and nucleus of the lateral recess (NRL). Scattered tac3-expressing cells are also present in telencephalic parts, such as ventral (Vv) and supracomissural (Vs) part of ventral telencephalon. In contrast to other teleosts, tac3 expression was absent from the pituitary. Using double-fluorescent staining, we localized tac3a-expressing cells in relation to GnRH and kisspeptin cells. Although no GnRH-tac3a colabeled cells were observed, dense GnRH fibers surround and potentially synapse with tac3a cells in the preoptic area. Only minimal (<5%) colabeling of tac3a was observed in kiss2 cells. Despite tac3a expression in many nodes of the mesolimbic reward system, it was absent from tyrosine hydroxylase (TH)-expressing cells, but tac3a cells were located in areas with dense TH fibers. The presence of tac3a-expressing cells throughout the brain, including in socially relevant brain regions, suggest more diverse functions beyond regulation of reproductive physiology that may be conserved across vertebrates.
Subject(s)
Brain/metabolism , Cichlids/metabolism , Lectins/biosynthesis , Animals , Cichlids/genetics , Dopaminergic Neurons/physiology , Female , Fishes/classification , Fishes/genetics , Gonadotropin-Releasing Hormone/analysis , Hypothalamus/metabolism , In Situ Hybridization , Kisspeptins/analysis , Lectins/genetics , Male , Organ Specificity , Phylogeny , Reproduction/genetics , Reproduction/physiology , Reward , Social BehaviorABSTRACT
Neuropathic pain represents a challenge to clinicians because it is resistant to commonly prescribed analgesics due to its largely unknown mechanisms. Here, we investigated a descending dopaminergic pathway-mediated modulation of trigeminal neuropathic pain. We performed chronic constriction injury of the infraorbital nerve from the maxillary branch of trigeminal nerve to induce trigeminal neuropathic pain in mice. Our retrograde tracing showed that the descending dopaminergic projection from hypothalamic A11 nucleus to spinal trigeminal nucleus caudalis is bilateral. Optogenetic/chemogenetic manipulation of dopamine receptors D1 and D2 in the spinal trigeminal nucleus caudalis produced opposite effects on the nerve injury-induced trigeminal neuropathic pain. Specific excitation of dopaminergic neurons in the A11 nucleus attenuated the trigeminal neuropathic pain through the activation of D2 receptors in the spinal trigeminal nucleus caudalis. Conversely, specific ablation of the A11 dopaminergic neurons exacerbated such pain. Our results suggest that the descending A11-spinal trigeminal nucleus caudalis dopaminergic projection is critical for the modulation of trigeminal neuropathic pain and could be manipulated to treat such pain.